Pharmacy
The drug decreases hospitalizations and deaths by 3%, which is not enough of a benefit to outweigh the risks, says one member.
Researchers found a significantly increased risk of infection with time elapsed since a second dose of the Pfizer/BioNTech vaccine.
There are many unknowns, including how effective current vaccines will be against the new variant, says Dr. Anthony Fauci.
Providers like funding for workforce training while PhRMA and others say bill would curb drug innovation.
Closings should be seen as a strategic move to revitalize the in-store experience. says Productsup spokesperson.
FDA has determined that the benefits of a single booster dose outweigh the risks and that the booster provides continued protection against COVID-19.
Each year opioid overdose, misuse and dependence account for $35 billion in healthcare costs.
One dose every 12 hours for five days reduces the rate of hospitalization or death due to COVID-19 by nearly 90%, Pfizer says.
New data submission requirements include information on average monthly premiums and drug spending for patients.
Workplace transmission is high and vaccination is the most effective mitigation measure, physician group says.